Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Developmental profiles in young children with Prader-Labhart-Willi syndrome: effects of weight and therapy with growth hormone or coenzyme Q10.

American journal of medical genetics. Part A - 1 Apr 2008

Eiholzer Urs, Meinhardt Udo, Rousson Valentin, Petrovic Nelica, Schlumpf Michael, l'Allemand Dagmar

Abstract excerpt

Muscle hypotonia and failure to thrive are key symptoms of Prader-Willi syndrome (PWS) allowing diagnosis during infancy already. Improved general care as well as Coenzyme Q(10) (CoQ(10)) and growth hormone (GH) are administered to improve PWS children's outcome. This study aims to investigate psychomotor development of young PWS children in relation to body weight and body composition at baseline as well as to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Developmental Disabilities
Share to Genotype

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Growth Hormone

Share to Infant

Share to Longitudinal Studies

Share to Prader-Willi Syndrome

Share to Sex Factors

Share to Ubiquinone

Source

Identifiers

PMID: 18257095
DOI: 10.1002/ajmg.a.32137

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Developmental profiles in young children with Prader-Labhart-Willi syndrome: effects of weight and therapy with growth hormone or coenzyme Q10.PMID 18257095Read ↗

Growth hormone improves body composition and motor development in infants with Prader-Willi syndrome after six months.Semantic proximity Read ↗

Schaaf-Yang Syndrome: Clinical Phenotype and Effects of 4 years of Growth Hormone Treatment.Semantic proximity Read ↗

[Clinical aspects and genetics of Prader-Willi syndrome].Semantic proximity Read ↗

The influence of genotype makeup on the effectiveness of growth hormone therapy in children with Prader-Willi syndrome.Semantic proximity Read ↗

Spontaneous growth in German children and adolescents with genetically confirmed Prader-Willi syndrome.Semantic proximity Read ↗

Cross-cultural comparisons of obesity and growth in Prader-Willi syndrome.Semantic proximity Read ↗

The transition between the phenotypes of Prader-Willi syndrome during infancy and early childhood.Semantic proximity Read ↗

Growth Trajectories in Genetic Subtypes of Prader-Willi Syndrome.Semantic proximity Read ↗

Anthropometric characteristics of newborns with Prader–Willi syndromeSemantic proximity Read ↗

Growth hormone therapy in young children with Down syndrome and a clinical comparison of Down and Prader-Willi syndromes.Semantic proximity Read ↗

Phenotypic heterogeneity of growth and psychometric intelligence in Prader-Willi syndrome: variable expression of a contiguous gene syndrome or parent-child resemblance?Semantic proximity Read ↗

Effect of Genotype and Previous GH Treatment on Adiposity in Adults With Prader-Willi Syndrome.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.